Clinical Trial: A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736638) titled 'A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants' on July 27.

Brief Summary: The objective of this study is to assess the pharmacokinetic (PK), immunogenicity, safety, and tolerability of ABBV-859 after single ascending doses in healthy adult volunteers.

Study Start Date: July 28

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-859

Oral Tablet

DRUG: Placebo for ABBV-859

Oral Tablet

DRUG: ABBV-859

Intravenous (IV) Infusion

DRUG: Placebo for ABBV-859

Intravenous (IV) Infusion

Recruitment Status: NOT_Y...